Clinical Trials

A clinical trial is a research study that allows volunteers to receive treatment with a drug or device currently under research testing by a pharmaceutical or biotechnology company. These companies carefully select qualified physicians who serve as "investigators” to lead the study trials.

Arkansas Children's offers opportunities to the community to participate in many studies. Use the search fields below to review the current available studies.

If you have questions about volunteering for research studies, please visit our Frequently Asked Questions page. 

If would like to be contacted about clinical research opportunities, consider joining our Research Registry or sign up to receive text updates on your mobile device.  CLICK HERE to learn more. 

See our currently enrolling studies list.

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old

The purpose of this study is to:

  • evaluate the pharmacokinetics (PK) of the research study drug, tedizolid phosphate (TZD), also known as SIVEXTRO, and its active metabolite tedizolid in subjects with known or suspected gram positive infection.
  • test the safety and tolerability of intravenous (IV) or oral TZD administration in pediatric subjects

This is a research study to test an investigational drug that has not been approved by the United States Food and Drug Administration (FDA) in children less than 2 years old.

This study has about 4 study visits that last over about 18 days.

Study Eligibility:  
male or female birth to less than 2 years old with suspected or confirmed gram negative infection
Content Study Link:  
Principal Investigator:  
Infection or Infectious Disease
Contact Information:  
Natalie James 501-364-2251,